Press Release: Immunophotonics : Immunophotonics Announces 1st Patient Dosed in Multinational Clinical trial in Germany

ST. LOUIS, MISSOURI, July 12, 2023 /⁨EINPresswire.com⁩/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the recruitment and the dosing of its first patient ...